Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Genesis Medical Interventional Inc.

This article was originally published in Start Up

Executive Summary

Genesis Medical Interventional is billing its F.A.S.T. (Facilitated Aspiration/Suction Thrombectomy) Funnel Catheter as "an elegantly simple solution" to more effectively remove particulate from the blood in cardiovascular disease. The funnel catheter is delivered proximal to the lesion, so that debris is captured upstream. The funnel occluder also harnesses native blood pressure for occlusion, which minimizes the device's force against the vessel wall.

You may also be interested in...



Embolic Protection: Unmet Clinical Need or Unneeded Technology

While the debate continues about whether embolic protection devices are really necessary, the space continues to generate interest from investors, start-ups and large companies looking for new technologies. Despite the unfulfilled promise of the past decade, interest has spread to new interventional applications such as percutaneous heart valves, indicating that this area remains a viable opportunity for start-ups.

Business and Technology Briefs

Brief summaries of recent product and company developments in the device industry, including: developments in cardiac stenting, DES competition heats up as the market stabilizes, and headaches for neuro device companies.

Business and Technology Briefs

Brief summaries of recent product and company developments in the device industry, including: developments in cardiac stenting, DES competition heats up as the market stabilizes, and headaches for neuro device companies.

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

MT037524

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel